v3.25.4
Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Common Stock [Member]
Previously Reported [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Previously Reported [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Previously Reported [Member]
Total
Previously Reported [Member]
Balance at Feb. 28, 2023        
Balances, shares at Feb. 28, 2023              
Issuance of common stock (Note 4) $ 90       90  
Issuance of common stock, shares 9,000,000              
Retroactive application of recapitalization $ 4,052   (4,052)      
Retroactive application of recapitalization, shares 32,420,154              
Retroactive application of reverse stock split $ (3,728)   3,728          
Retroactive application of reverse stock split, shares (37,278,138)              
Balance at Mar. 15, 2023 $ 414   (324)     90  
Balance, shares at Mar. 15, 2023 4,142,016              
Stock based compensation (Note 5)   58,536     58,536  
Transfer from early exercised stock option liability on vesting (Note 5)   200     200  
Issuance of common stock related to early exercised stock options        
Issuance of common stock related to early exercised stock options, shares 227,810              
Repurchase of unvested early exercised common stock        
Repurchase of unvested early exercise stock options, shares (92,045)              
Repurchase of common stock $ (12)   9     (3)  
Repurchase of common stock, shares (127,804)              
Net loss     (3,793,585)   (3,793,585)  
Repurchase of unvested early exercised common stock, shares 92,045              
Balance at Dec. 31, 2023 $ 402 [1] $ 402 58,421 [1] $ 58,421 (3,793,585) $ (3,793,585) (3,734,762) $ (3,734,762)
Balance, shares at Dec. 31, 2023 4,149,977 [1] 4,149,977            
Balance at Nov. 30, 2023 $ 87 [1] $ 87 58,736 [1] 58,736 (3,793,585) (3,793,585) (3,734,762) (3,734,762)
Balances, shares at Nov. 30, 2023 9,017,300 [1] 9,017,300            
Retroactive application of recapitalization $ 3,936 [1] $ 3,936 (3,936) [1] (3,936)
Retroactive application of recapitalization, shares [1] 32,482,472              
Retroactive application of reverse stock split $ (3,621) [1] (3,621) 3,621 [1] 3,621    
Retroactive application of reverse stock split, shares [1] (37,349,795)              
Balance at Dec. 31, 2023 $ 402 [1] $ 402 58,421 [1] 58,421 (3,793,585) (3,793,585) (3,734,762) (3,734,762)
Balance, shares at Dec. 31, 2023 4,149,977 [1] 4,149,977            
Stock based compensation (Note 5) [1]   59,599 [1]     59,599  
Transfer from early exercised stock option liability on vesting (Note 5) [1]   100 [1]     100  
Net loss [1]   [1]   (1,399,213)   (1,399,213)  
Balance at Mar. 31, 2024 $ 402 [1]   118,120 [1]   (5,192,798)   (5,074,276)  
Balance, shares at Mar. 31, 2024 [1] 4,149,977              
Balance at Dec. 31, 2023 $ 402 [1] $ 402 58,421 [1] 58,421 (3,793,585) (3,793,585) (3,734,762) (3,734,762)
Balances, shares at Dec. 31, 2023 4,149,977 [1] 4,149,977            
Net loss             (14,185,887)  
Balance at Sep. 30, 2024 $ 457 [1]   29,745,905 [1]   (43,050,972)   (13,304,610)  
Balance, shares at Sep. 30, 2024 [1] 4,787,246              
Balance at Dec. 31, 2023 $ 402 [1] $ 402 58,421 [1] 58,421 (3,793,585) (3,793,585) (3,734,762) (3,734,762)
Balances, shares at Dec. 31, 2023 4,149,977 [1] 4,149,977            
Issuance of common stock (Note 4)   $ 1   268,997     268,998
Issuance of common stock, shares 5,583              
Stock based compensation (Note 5)     9,750,511     9,750,511
Transfer from early exercised stock option liability on vesting (Note 5)   3   2,352     2,355
Repurchase of unvested early exercised common stock        
Repurchase of unvested early exercise stock options, shares (25,570)              
Net loss       (23,753,863) (23,753,863) (23,753,863)
Synthetic at-the-market (“ATM”) commitment fee   1   499,999     500,000
Synthetic at-the-market ("ATM") commitment fee, shares 6,369              
Shares issued upon exercise of common stock warrants   1   1,626,618     1,626,619
Shares issued upon exercise of common stock warrants, shares $ 13,580              
Shares issued upon conversion of SAFE notes   6   6,367,194     6,367,200
Shares issued upon conversion of SAFE notes, shares $ 63,692              
Shares issued upon conversion of convertible notes   3   2,571,397     2,571,400
Shares issued upon conversion of convertible notes, shares 25,722              
Issuance of common stock upon the reverse capitalization including PIPE financing, net of transaction costs   43   (5,483,062)     (5,483,019)
Issuance of common stock upon the reverse capitalization including PIPE financing, net of transaction costs, shares 534,275              
Transaction costs     (7,501,223)   (7,501,223) (7,501,223)
Merger earnout shares (Note 3)     25,071,500   (25,071,500)  
Repurchase of unvested early exercised common stock, shares 25,570              
Balance at Dec. 31, 2024 $ 460 [1] $ 460 33,232,704 [1] 33,232,704 (52,618,948) (52,618,948) (19,385,784) (19,385,784)
Balance, shares at Dec. 31, 2024 4,773,628 [1] 4,773,628 [2]            
Balance at Mar. 31, 2024 $ 402 [1]   118,120 [1]   (5,192,798)   (5,074,276)  
Balances, shares at Mar. 31, 2024 [1] 4,149,977              
Stock based compensation (Note 5)     58,125 [1]     58,125  
Transfer from early exercised stock option liability on vesting (Note 5) [1]   100 [1]     100  
Net loss         (2,694,362)   (2,694,362)  
Balance at Jun. 30, 2024 $ 402 [1]   176,345 [1]   (7,887,160)   (7,710,413)  
Balance, shares at Jun. 30, 2024 [1] 4,149,977              
Stock based compensation (Note 5) [1]   6,916,355 [1]     6,916,355  
Transfer from early exercised stock option liability on vesting (Note 5) 1 [1]   782 [1]     783  
Net loss         (10,092,312)   (10,092,312)  
Shares issued upon exercise of common stock warrants 1 [1]   1,626,618 [1]     1,626,619  
Shares issued upon exercise of common stock warrants, shares [1] 13,580              
Shares issued upon conversion of SAFE notes 6 [1]   6,367,194 [1]     6,367,200  
Shares issued upon conversion of SAFE notes, shares [1] 63,692              
Shares issued upon conversion of convertible notes $ 3 [1]   2,571,397 [1]     2,571,400  
Shares issued upon conversion of convertible notes, shares [1] 25,722              
Transaction costs [1]   (7,501,223) [1]     (7,501,223)  
Merger earnout shares (Note 3) [1]   25,071,500 [1]   (25,071,500)    
Issuance of common stock upon the reverse capitalization including PIPE financing, net of assumed liabilities $ 44 [1]   (5,483,063) [1]     (5,483,019)  
Issuance of common stock upon the reverse capitalization including PIPE financing, net of transaction costs, shares [1] 534,275              
Balance at Sep. 30, 2024 $ 457 [1]   29,745,905 [1]   (43,050,972)   (13,304,610)  
Balance, shares at Sep. 30, 2024 [1] 4,787,246              
Balance at Dec. 31, 2024 $ 460 [1] $ 460 33,232,704 [1] 33,232,704 (52,618,948) (52,618,948) (19,385,784) (19,385,784)
Balances, shares at Dec. 31, 2024 4,773,628 [1] 4,773,628 [2]            
Issuance of common stock (Note 4) [1]   16,414 [1]     16,414  
Issuance of common stock, shares [1] 398              
Stock based compensation (Note 5) [1]   2,954,279 [1]     2,954,279  
Transfer from early exercised stock option liability on vesting (Note 5) 1 [1]   360 [1]     361  
Repurchase of unvested early exercised common stock [1]   [1]      
Repurchase of unvested early exercise stock options, shares [1] 24,449              
Net loss [1]   [1]   (3,809,700)   (3,809,700)  
Issuance of common stock and warrants from January 2025 public offering, net of offering costs $ 48 [1]   4,591,021 [1]     4,591,069  
Issuance of common stock and warrants from January 2025 public offering, net of offering costs, shares [1] 479,200              
Issuance of common stock upon warrant inducement, net of offering costs $ 48 [1]   2,798,151 [1]     2,798,199  
Issuance of common stock upon warrant inducement, net of offering costs, shares [1] 479,200              
Repurchase of unvested early exercised common stock, shares [1] (24,449)              
Issuance of common stock for settlement of RSU $ 6 [1]   (6) [1]      
Issuance of common stock for settlement of RSU, shares [1] 57,071              
Balance at Mar. 31, 2025 $ 563 [1]   43,592,923 [1]   (56,428,648)   (12,835,162)  
Balance, shares at Mar. 31, 2025 [1] 5,765,048              
Balance at Dec. 31, 2024 $ 460 [1] $ 460 33,232,704 [1] $ 33,232,704 (52,618,948) $ (52,618,948) (19,385,784) $ (19,385,784)
Balances, shares at Dec. 31, 2024 4,773,628 [1] 4,773,628 [2]            
Net loss             (11,973,902)  
Balance at Sep. 30, 2025 $ 883 [1]   59,471,853 [1]   (64,592,850)   (5,120,114)  
Balance, shares at Sep. 30, 2025 [1] 8,954,343              
Balance at Mar. 31, 2025 $ 563 [1]   43,592,923 [1]   (56,428,648)   (12,835,162)  
Balances, shares at Mar. 31, 2025 [1] 5,765,048              
Issuance of common stock (Note 4) $ 2 [1]   106,134 [1]     106,136  
Issuance of common stock, shares [1] 16,062              
Stock based compensation (Note 5)     1,426,400 [1]     1,426,400  
Transfer from early exercised stock option liability on vesting (Note 5) [1]   313 [1]     313  
Net loss [1]   [1]   (3,704,438)   (3,704,438)  
Issuance of common stock for settlement of RSU $ 14 [1]   (14) [1]      
Issuance of common stock for settlement of RSU, shares [1] 135,340              
Issuance of common stock to short- term loan holders (Note 14) $ 17 [1]   6,199,983 [1]     6,200,000  
Issuance of common stock to short- Term loan holders, shares [1] 173,184              
Issuance of common stock to PIPE investors (Note 4) $ 1 [1]   549,999 [1]     550,000  
Issuance of common stock to PIPE investors, shares [1] 12,850              
Issuance of common stock to vendor $ 1 [1]   80,611 [1]     80,612  
Issuance of common stock to vendor, shares [1] 15,000              
Issuance of common stock under license arrangement (Note 4) $ 5 [1]   342,995 [1]     343,000  
Issuance of common stock to KMX, shares [1] 50,000              
Issuance of common stock from public offering, net of offering costs $ 226 [1]   3,945,449 [1]     3,945,675  
Issuance of common stock from public offering, shares [1] 2,260,000              
Balance at Jun. 30, 2025 $ 829 [1]   56,244,793 [1]   (60,133,086)   (3,887,464)  
Balance, shares at Jun. 30, 2025 [1] 8,427,484              
Issuance of common stock (Note 4) $ 49 [1]   1,524,832 [1]     1,524,881  
Issuance of common stock, shares [1] 488,811              
Stock based compensation (Note 5)     1,702,265 [1]     1,702,265  
Transfer from early exercised stock option liability on vesting (Note 5) $ 1 [1]   312 [1]     313  
Net loss [1]   [1]   (4,459,764)   (4,459,764)  
Issuance of common stock for settlement of RSU $ 4 [1]   (4) [1]      
Issuance of common stock for settlement of RSU, shares [1] 38,163              
Fractional share adjustment due to reverse stock split [1]   (345) [1]     (345)  
Fractional share adjustment due to reverse stock split, shares [1] (115)              
Balance at Sep. 30, 2025 $ 883 [1]   $ 59,471,853 [1]   $ (64,592,850)   $ (5,120,114)  
Balance, shares at Sep. 30, 2025 [1] 8,954,343              
[1] Amounts have been adjusted to reflect the 1-for-10 reverse stock split that became effective on September 8, 2025. See Note 2 “Basis of presentation and summary of significant accounting policies” for additional details.
[2] Amounts have been adjusted to reflect the